FDA Mostly Improving Generic-Drug Inspections, Report Finds
A congressionally requested review of the U.S. Food and Drug Administration's inspections of generic-drug manufacturers has concluded that the agency's oversight increased between 2011 and 2013, but found that it still...To view the full article, register now.
Already a subscriber? Click here to view full article